Risk of venous and arterial thromboembolic events associated with anti-VEGF agents in advanced non-small-cell lung cancer: a meta-analysis and systematic review

AIMS: To assess the incidence and risk of arterial and venous thromboembolic events (ATEs and VTEs) associated with antivascular endothelial growth factor (VEGF) agents, including VEGF receptor-tyrosine kinase inhibitors and VEGF monoclonal antibodies, in advanced non-small-cell lung cancer (NSCLC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dianbao, Zhang, Xianfen, Zhao, Chunling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922760/
https://www.ncbi.nlm.nih.gov/pubmed/27382307
http://dx.doi.org/10.2147/OTT.S103735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922760/
https://www.ncbi.nlm.nih.gov/pubmed/27382307
http://dx.doi.org/10.2147/OTT.S103735

Ejemplares similares